ResearcherNorthwell HealthActive in the last 2 years
Sandeep Nadella
Matched on ORCID iD 0000-0002-3290-4018; OpenAlex author ID A5049643420. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2018: 3 papers · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 6
- Computationally assisted patient finding for navigation to optimize pancreatic cancer care access. Co-author DOI 10.1093/oncolo/oyag037↗
- Does Chronic Use of High Dose Proton Pump Inhibitors Increase Risk for Pancreatic Cancer? First author DOI 10.1097/mpa.0000000000002145↗
- Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastases. Co-author DOI 10.1152/ajpgi.00145.2019↗
- Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. Co-author DOI 10.1007/s00262-017-2077-9↗
- Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer. First author DOI 10.1016/j.jcmgh.2018.02.013↗
- Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor. Co-author DOI 10.1152/ajpgi.00123.2018↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jill Palmer Smith · 5 shared papers, 2018–2022 · strength 0.49
- Paper Does Chronic Use of High Dose Proton Pump Inhibitors Increase Risk for Pancreatic Cancer? DOI 10.1097/mpa.0000000000002145↗
- Paper Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoi… DOI 10.1007/s00262-017-2077-9↗
- Paper Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastases. DOI 10.1152/ajpgi.00145.2019↗
- Richard D. Carvajal · 1 shared paper, 2026 · strength 0.24
- Daniel A. King · 1 shared paper, 2026 · strength 0.24
- David Arthur Tuveson · 1 shared paper, 2026 · strength 0.24
- Julian Burks · 2 shared papers, 2018 · strength 0.16
- Paper Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer. DOI 10.1016/j.jcmgh.2018.02.013↗
- Paper Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecy… DOI 10.1152/ajpgi.00123.2018↗
- Matthew Huber · 1 shared paper, 2022 · strength 0.14
- Louis M. Weiner · 1 shared paper, 2018 · strength 0.11
- Nicholas Osborne · 1 shared paper, 2019 · strength 0.09
- Stęphan T. Stern · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.